Literature DB >> 30726833

Group 2 Innate Lymphoid Cells in Human Respiratory Disorders.

Esmee K van der Ploeg1,2, Ana Carreras Mascaro3, Danny Huylebroeck1, Rudi W Hendriks2, Ralph Stadhouders4,5.   

Abstract

Recent studies using animal models have generated profound insight into the functions of various subsets of innate lymphoid cells (ILCs). The group 2 ILC subset (ILC2) has been implicated in tissue homeostasis, defense responses against parasites, tissue repair, and immunopathology associated with type-2 immunity. In addition, progress has also been made in translating these findings from animal studies into a context of human immunity. Importantly, recent observations strongly support a role for ILC2s in several diseases of the human respiratory system. However, many aspects of human ILC2 biology are still unclear, including how these cells develop and which signals control their activity. As a result, the exact role played by ILCs in human health and disease remains poorly understood. Here, we summarize our current understanding of human ILC2 biology and focus on their potential involvement in various human respiratory disorders.
© 2018 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Allergy; Asthma; ILC2; Innate lymphoid cell; Lung; Plasticity

Year:  2019        PMID: 30726833      PMCID: PMC6959098          DOI: 10.1159/000496212

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  149 in total

1.  T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(-)CD7(+) common lymphoid progenitors expressing lymphoid-specific genes.

Authors:  I Hoebeke; M De Smedt; F Stolz; K Pike-Overzet; F J T Staal; J Plum; G Leclercq
Journal:  Leukemia       Date:  2006-12-14       Impact factor: 11.528

2.  GITR cosignal in ILC2s controls allergic lung inflammation.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Tsuyoshi Fujita; Takeo Takeda; Yasutaka Motomura; Kazuyo Moro; Takanori Hidaka; Koki Omori; Tsuyoshi Sakurai; Tomoaki Machiyama; Lishomwa C Ndhlovu; Carlo Riccardi; Takanori So; Naoto Ishii
Journal:  J Allergy Clin Immunol       Date:  2018-02-08       Impact factor: 10.793

Review 3.  Chronic obstructive pulmonary disease.

Authors:  Klaus F Rabe; Henrik Watz
Journal:  Lancet       Date:  2017-05-11       Impact factor: 79.321

Review 4.  Human innate lymphoid cells.

Authors:  Mette D Hazenberg; Hergen Spits
Journal:  Blood       Date:  2014-04-28       Impact factor: 22.113

5.  IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity.

Authors:  Yoichiro Ohne; Jonathan S Silver; LuAnn Thompson-Snipes; Magalie A Collet; Jean Philippe Blanck; Brandi L Cantarel; Alan M Copenhaver; Alison A Humbles; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

6.  IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells.

Authors:  Yuefeng Huang; Liying Guo; Jin Qiu; Xi Chen; Jane Hu-Li; Ulrich Siebenlist; Peter R Williamson; Joseph F Urban; William E Paul
Journal:  Nat Immunol       Date:  2014-12-22       Impact factor: 25.606

7.  Allergen-Dependent Differences in ILC2s Frequencies in Patients With Allergic Rhinitis.

Authors:  Dachuan Fan; Xiangdong Wang; Min Wang; Yang Wang; Liang Zhang; Ying Li; Erzhong Fan; Feifei Cao; Koen Van Crombruggen; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2016-05       Impact factor: 5.764

8.  PD-1 regulates KLRG1+ group 2 innate lymphoid cells.

Authors:  Samuel Taylor; Yuefeng Huang; Grace Mallett; Chaido Stathopoulou; Tania C Felizardo; Ming-An Sun; Evelyn L Martin; Nathaniel Zhu; Emma L Woodward; Martina S Elias; Jonathan Scott; Nick J Reynolds; William E Paul; Daniel H Fowler; Shoba Amarnath
Journal:  J Exp Med       Date:  2017-05-10       Impact factor: 14.307

9.  Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation.

Authors:  Ari B Molofsky; Frédéric Van Gool; Hong-Erh Liang; Steven J Van Dyken; Jesse C Nussbaum; Jinwoo Lee; Jeffrey A Bluestone; Richard M Locksley
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

10.  Type 2 innate lymphoid cells control eosinophil homeostasis.

Authors:  Jesse C Nussbaum; Steven J Van Dyken; Jakob von Moltke; Laurence E Cheng; Alexander Mohapatra; Ari B Molofsky; Emily E Thornton; Matthew F Krummel; Ajay Chawla; Hong-Erh Liang; Richard M Locksley
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

View more
  14 in total

1.  Skeletons in the Cupboard of Dysfunctional Neutrophils Revealed.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2021-01-21       Impact factor: 7.349

2.  Notch signaling licenses allergic airway inflammation by promoting Th2 cell lymph node egress.

Authors:  Irma Tindemans; Anne van Schoonhoven; Alex KleinJan; Marjolein Jw de Bruijn; Melanie Lukkes; Menno van Nimwegen; Anouk van den Branden; Ingrid M Bergen; Odilia Bj Corneth; Wilfred Fj van IJcken; Ralph Stadhouders; Rudi W Hendriks
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 3.  Different Phenotypes in Asthma: Clinical Findings and Experimental Animal Models.

Authors:  Luiz Otávio Lourenço; Alessandra Mussi Ribeiro; Fernanda Degobbi Tenório Quirino Dos Santos Lopes; Iolanda de Fátima Lopes Calvo Tibério; Wothan Tavares-de-Lima; Carla Máximo Prado
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-20       Impact factor: 8.667

Review 4.  Mucosal Immunity in Cystic Fibrosis.

Authors:  Christine M Bojanowski; Shiping Lu; Jay K Kolls
Journal:  J Immunol       Date:  2021-12-15       Impact factor: 5.426

5.  ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure.

Authors:  Anja Schulz-Kuhnt; Vicky Greif; Kai Hildner; Lisa Knipfer; Michael Döbrönti; Sabine Zirlik; Florian Fuchs; Raja Atreya; Sebastian Zundler; Rocío López-Posadas; Clemens Neufert; Andreas Ramming; Alexander Kiefer; Anika Grüneboom; Erwin Strasser; Stefan Wirtz; Markus F Neurath; Imke Atreya
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

6.  3D genome organization during lymphocyte development and activation.

Authors:  Anne van Schoonhoven; Danny Huylebroeck; Rudi W Hendriks; Ralph Stadhouders
Journal:  Brief Funct Genomics       Date:  2020-03-23       Impact factor: 4.241

7.  Innate Immunity of the Lung.

Authors:  Catherine M Greene; Pieter S Hiemstra
Journal:  J Innate Immun       Date:  2019-12-04       Impact factor: 7.349

Review 8.  A Potential Role of Group 2 Innate Lymphoid Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps.

Authors:  Yan Li; Wei Wang; Sun Ying; Feng Lan; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2021-05       Impact factor: 5.764

9.  Bronchiolitis and recurrent wheezing are distinguished by type 2 innate lymphoid cells and immune response.

Authors:  Beatriz Sastre; María Luz García-García; José Antonio Cañas; Cristina Calvo; José Manuel Rodrigo-Muñoz; Inmaculada Casas; Ignacio Mahíllo-Fernández; Victoria Del Pozo
Journal:  Pediatr Allergy Immunol       Date:  2020-07-23       Impact factor: 5.464

Review 10.  Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.

Authors:  Jie Jin; Sadik Sunusi; Hongyan Lu
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.